Bradford Whitmore Acquires 32,876 Shares of Ultralife (NASDAQ:ULBI) Stock

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore acquired 32,876 shares of the stock in a transaction dated Thursday, May 21st. The stock was bought at an average price of $6.13 per share, for a total transaction of $201,529.88. Following the purchase, the director owned 1,974,635 shares of the company’s stock, valued at $12,104,512.55. The trade was a 1.69% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Ultralife Trading Up 13.0%

Shares of Ultralife stock opened at $7.75 on Thursday. The company’s fifty day simple moving average is $6.77 and its 200-day simple moving average is $6.24. The company has a market cap of $129.12 million, a price-to-earnings ratio of -15.50 and a beta of 0.74. The company has a current ratio of 2.56, a quick ratio of 1.23 and a debt-to-equity ratio of 0.34. Ultralife Corporation has a 1 year low of $4.90 and a 1 year high of $9.52.

Ultralife (NASDAQ:ULBI) last announced its quarterly earnings data on Friday, May 8th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.18). The company had revenue of $47.45 million during the quarter, compared to analyst estimates of $52.40 million. Ultralife had a positive return on equity of 1.15% and a negative net margin of 4.37%.

Institutional Investors Weigh In On Ultralife

Hedge funds and other institutional investors have recently modified their holdings of the stock. Empowered Funds LLC acquired a new stake in shares of Ultralife in the fourth quarter worth $44,000. Lazard Asset Management LLC grew its stake in shares of Ultralife by 1,650.0% in the second quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company’s stock worth $49,000 after acquiring an additional 5,247 shares during the last quarter. Prelude Capital Management LLC acquired a new stake in shares of Ultralife in the third quarter worth $71,000. Jane Street Group LLC acquired a new stake in shares of Ultralife in the fourth quarter worth $75,000. Finally, Jones Financial Companies Lllp grew its stake in shares of Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after acquiring an additional 14,287 shares during the last quarter. Institutional investors and hedge funds own 30.68% of the company’s stock.

Ultralife Company Profile

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.